ISIN | CH0506063244 |
---|---|
Valor Number | 50606324 |
Bloomberg Global ID | |
Fund Name | UBAM (CH) - Swiss Equity (CHF) I |
Fund Provider |
Union Bancaire Privée, UBP SA
Genève 1, Switzerland Phone: +41 22 819 28 00 E-Mail: ubpfunds@ubp.com Web: www.ubp.com |
Fund Provider | Union Bancaire Privée, UBP SA |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Swiss Equity sub-fund aims in the medium term, to generate superior returns relative to the Swiss equity market as measured by the SPI® index. The sub-fund is actively managed and the companies are chosen after a rigorous and diverse selection process. No guarantee can be given as to the achievement of the sub-fund's investment objective. |
Peculiarities |
Current Price * | 111.71 CHF | 11.11.2024 |
---|---|---|
Previous Price * | 110.66 CHF | 08.11.2024 |
52 Week High * | 114.92 CHF | 30.08.2024 |
52 Week Low * | 94.29 CHF | 13.11.2023 |
NAV * | 111.71 CHF | 11.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 12,060,232 | |
Unit/Share Assets *** | 11,682,961 | |
Trading Information SIX |
YTD Performance | +12.09% |
31.12.2023 - 11.11.2024
31.12.2023 11.11.2024 |
---|---|---|
1 month | -0.96% |
11.10.2024 - 11.11.2024
11.10.2024 11.11.2024 |
3 months | +1.75% |
12.08.2024 - 11.11.2024
12.08.2024 11.11.2024 |
6 months | +2.92% |
13.05.2024 - 11.11.2024
13.05.2024 11.11.2024 |
1 year | +18.47% |
13.11.2023 - 11.11.2024
13.11.2023 11.11.2024 |
2 years | +12.26% |
11.11.2022 - 11.11.2024
11.11.2022 11.11.2024 |
3 years | -11.34% |
11.11.2021 - 11.11.2024
11.11.2021 11.11.2024 |
5 years | +20.13% |
13.11.2019 - 11.11.2024
13.11.2019 11.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 11.75% | |
---|---|---|
Nestle SA | 11.42% | |
Novartis AG Registered Shares | 9.15% | |
ABB Ltd | 7.34% | |
UBS Group AG | 5.21% | |
Alcon Inc | 4.00% | |
Zurich Insurance Group AG | 3.39% | |
Lonza Group Ltd | 3.37% | |
Sika AG | 3.15% | |
Accelleron Industries AG Ordinary Shares | 2.61% | |
Last data update | 31.07.2024 |
TER | 0.90% |
---|---|
TER date | 30.04.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 1.18% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |